If we don’t receive any news on BLA submission before the end of the year. We should receive news on CLBP as per the the Q1 financial highlights and results
”Working towards FDA clearance by year end 2022 to commence the second Phase 3 trial for potential marketing approval in chronic lower back pain due to degenerative disc disease”.
One way or another price activity should occur - IMO.
Merry Christmas and GLTAH!
- Forums
- ASX - By Stock
- GVHD the first step
If we don’t receive any news on BLA submission before the end of...
- There are more pages in this discussion • 124 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
0.070(6.45%) |
Mkt cap ! $1.318B |
Open | High | Low | Value | Volume |
$1.12 | $1.20 | $1.11 | $20.88M | 17.94M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 59978 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 34019 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 59978 | 1.150 |
9 | 317014 | 1.145 |
2 | 42121 | 1.140 |
8 | 119942 | 1.130 |
4 | 55950 | 1.125 |
Price($) | Vol. | No. |
---|---|---|
1.155 | 25519 | 2 |
1.160 | 51465 | 2 |
1.165 | 57384 | 5 |
1.170 | 62000 | 4 |
1.180 | 14000 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.15 |
  |
Change
0.070 ( 5.63 %) |
|||
Open | High | Low | Volume | ||
$1.12 | $1.20 | $1.12 | 3733217 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online